186 related articles for article (PubMed ID: 22570527)
21.
Ren J; Zhu S; Zhang G; Tan X; Qiu L; Lin J; Jiang L
Mol Pharm; 2022 Jul; 19(7):2620-2628. PubMed ID: 35674464
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature.
Chen K; Sun X; Niu G; Ma Y; Yap LP; Hui X; Wu K; Fan D; Conti PS; Chen X
Mol Imaging Biol; 2012 Feb; 14(1):96-105. PubMed ID: 21360213
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
[TBL] [Abstract][Full Text] [Related]
25. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
Kumar SR; Deutscher SL
J Nucl Med; 2008 May; 49(5):796-803. PubMed ID: 18413389
[TBL] [Abstract][Full Text] [Related]
26. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
Chen X; Park R; Shahinian AH; Tohme M; Khankaldyyan V; Bozorgzadeh MH; Bading JR; Moats R; Laug WE; Conti PS
Nucl Med Biol; 2004 Feb; 31(2):179-89. PubMed ID: 15013483
[TBL] [Abstract][Full Text] [Related]
27. Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging.
Moore SJ; Leung CL; Norton HK; Cochran JR
PLoS One; 2013; 8(4):e60498. PubMed ID: 23573262
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.
Dijkgraaf I; Kruijtzer JA; Frielink C; Soede AC; Hilbers HW; Oyen WJ; Corstens FH; Liskamp RM; Boerman OC
Nucl Med Biol; 2006 Nov; 33(8):953-61. PubMed ID: 17127167
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
McQuade P; Knight LC; Welch MJ
Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
[TBL] [Abstract][Full Text] [Related]
30. A human transferrin-vascular endothelial growth factor (hnTf-VEGF) fusion protein containing an integrated binding site for (111)In for imaging tumor angiogenesis.
Chan C; Sandhu J; Guha A; Scollard DA; Wang J; Chen P; Bai K; Lee L; Reilly RM
J Nucl Med; 2005 Oct; 46(10):1745-52. PubMed ID: 16204726
[TBL] [Abstract][Full Text] [Related]
31. Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation.
Silverman AP; Kariolis MS; Cochran JR
J Mol Recognit; 2011; 24(1):127-35. PubMed ID: 21194123
[TBL] [Abstract][Full Text] [Related]
32. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
33. In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone.
Liu D; Overbey D; Watkinson LD; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA; Giblin MF
Anticancer Res; 2009 Oct; 29(10):3777-83. PubMed ID: 19846908
[TBL] [Abstract][Full Text] [Related]
34. PET of vascular endothelial growth factor receptor expression.
Cai W; Chen K; Mohamedali KA; Cao Q; Gambhir SS; Rosenblum MG; Chen X
J Nucl Med; 2006 Dec; 47(12):2048-56. PubMed ID: 17138749
[TBL] [Abstract][Full Text] [Related]
35. Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591.
Tolmachev V; Varasteh Z; Honarvar H; Hosseinimehr SJ; Eriksson O; Jonasson P; Frejd FY; Abrahmsen L; Orlova A
J Nucl Med; 2014 Feb; 55(2):294-300. PubMed ID: 24408895
[TBL] [Abstract][Full Text] [Related]
36. Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice.
Lo WL; Lo SW; Chen SJ; Chen MW; Huang YR; Chen LC; Chang CH; Li MH
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064291
[TBL] [Abstract][Full Text] [Related]
37. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.
Zheng Y; Ji S; Tomaselli E; Yang Y; Liu S
Nucl Med Biol; 2015 Feb; 42(2):137-45. PubMed ID: 25459111
[TBL] [Abstract][Full Text] [Related]
38. Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues.
Cheng Z; Chen J; Miao Y; Owen NK; Quinn TP; Jurisson SS
J Med Chem; 2002 Jul; 45(14):3048-56. PubMed ID: 12086490
[TBL] [Abstract][Full Text] [Related]
39. Effects of the amino acid linkers on the melanoma-targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-MSH peptides.
Guo H; Yang J; Gallazzi F; Miao Y
J Nucl Med; 2011 Apr; 52(4):608-16. PubMed ID: 21421725
[TBL] [Abstract][Full Text] [Related]
40. 99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.
Zhu X; Li J; Hong Y; Kimura RH; Ma X; Liu H; Qin C; Hu X; Hayes TR; Benny P; Gambhir SS; Cheng Z
Mol Pharm; 2014 Apr; 11(4):1208-17. PubMed ID: 24524409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
